 | • レポートコード：D005-08446 • 出版社/出版日：GlobalInfoResearch / 2020年5月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、イマチニブ薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。イマチニブ薬の種類別市場規模（錠剤、カプセル）、用途別市場規模（慢性骨髄性白血病、消化管間質腫瘍、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Novartis、Cipla Inc.、Actavis Generics、Glenmark Pharmaceuticals Ltd.、Sanofi S.A.、Sun Pharmaceuticals、Mylan Pharms Inc.、Teva Pharmaceutical Industries Ltd.、Dr. Reddy's Laboratories、Apotex Inc. ・地域別グローバル市場分析 2015年-2020年 ・イマチニブ薬の北米市場（アメリカ、カナダ、メキシコ） ・イマチニブ薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・イマチニブ薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・イマチニブ薬の南米市場（ブラジル、アルゼンチン） ・イマチニブ薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：錠剤、カプセル ・用途別分析：慢性骨髄性白血病、消化管間質腫瘍、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Imatinib Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Imatinib Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Imatinib Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Imatinib Drug market has been segmented into
Tablets
Capsules
By Application, Imatinib Drug has been segmented into:
Chronic myelogenous leukemia
Gastrointestinal stromal tumors
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Imatinib Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Imatinib Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Imatinib Drug market.
The report offers in-depth assessment of the growth and other aspects of the Imatinib Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Imatinib Drug Market Share Analysis
Imatinib Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Imatinib Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Imatinib Drug sales, revenue and market share for each player covered in this report.
The major players covered in Imatinib Drug are:
Novartis
Cipla Inc.
Actavis Generics
Glenmark Pharmaceuticals Ltd.
Sanofi S.A.
Sun Pharmaceuticals
Mylan Pharms Inc.
Teva Pharmaceutical Industries Ltd.
Dr. Reddy’s Laboratories
Apotex Inc.
Among other players domestic and global, Imatinib Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Imatinib Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Imatinib Drug, with price, sales, revenue and global market share of Imatinib Drug in 2018 and 2019.
Chapter 3, the Imatinib Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Imatinib Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Imatinib Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Imatinib Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Imatinib Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Imatinib Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Tablets
1.2.3 Capsules
1.3 Market Analysis by Application
1.3.1 Overview: Global Imatinib Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Chronic myelogenous leukemia
1.3.3 Gastrointestinal stromal tumors
1.3.4 Others
1.4 Overview of Global Imatinib Drug Market
1.4.1 Global Imatinib Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis SWOT Analysis
2.1.4 Novartis Product and Services
2.1.5 Novartis Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Cipla Inc.
2.2.1 Cipla Inc. Details
2.2.2 Cipla Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Cipla Inc. SWOT Analysis
2.2.4 Cipla Inc. Product and Services
2.2.5 Cipla Inc. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Actavis Generics
2.3.1 Actavis Generics Details
2.3.2 Actavis Generics Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Actavis Generics SWOT Analysis
2.3.4 Actavis Generics Product and Services
2.3.5 Actavis Generics Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Glenmark Pharmaceuticals Ltd.
2.4.1 Glenmark Pharmaceuticals Ltd. Details
2.4.2 Glenmark Pharmaceuticals Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Glenmark Pharmaceuticals Ltd. SWOT Analysis
2.4.4 Glenmark Pharmaceuticals Ltd. Product and Services
2.4.5 Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sanofi S.A.
2.5.1 Sanofi S.A. Details
2.5.2 Sanofi S.A. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sanofi S.A. SWOT Analysis
2.5.4 Sanofi S.A. Product and Services
2.5.5 Sanofi S.A. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sun Pharmaceuticals
2.6.1 Sun Pharmaceuticals Details
2.6.2 Sun Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Sun Pharmaceuticals SWOT Analysis
2.6.4 Sun Pharmaceuticals Product and Services
2.6.5 Sun Pharmaceuticals Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Mylan Pharms Inc.
2.7.1 Mylan Pharms Inc. Details
2.7.2 Mylan Pharms Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Mylan Pharms Inc. SWOT Analysis
2.7.4 Mylan Pharms Inc. Product and Services
2.7.5 Mylan Pharms Inc. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Teva Pharmaceutical Industries Ltd.
2.8.1 Teva Pharmaceutical Industries Ltd. Details
2.8.2 Teva Pharmaceutical Industries Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Teva Pharmaceutical Industries Ltd. SWOT Analysis
2.8.4 Teva Pharmaceutical Industries Ltd. Product and Services
2.8.5 Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Dr. Reddy’s Laboratories
2.9.1 Dr. Reddy’s Laboratories Details
2.9.2 Dr. Reddy’s Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Dr. Reddy’s Laboratories SWOT Analysis
2.9.4 Dr. Reddy’s Laboratories Product and Services
2.9.5 Dr. Reddy’s Laboratories Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Apotex Inc.
2.10.1 Apotex Inc. Details
2.10.2 Apotex Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Apotex Inc. SWOT Analysis
2.10.4 Apotex Inc. Product and Services
2.10.5 Apotex Inc. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Imatinib Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Imatinib Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Imatinib Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Imatinib Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Imatinib Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Imatinib Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Imatinib Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Imatinib Drug Sales and Growth Rate (2015-2020)
4.3 Europe Imatinib Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Imatinib Drug Sales and Growth Rate (2015-2020)
4.5 South America Imatinib Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Imatinib Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Imatinib Drug Sales, Revenue and Market Share by Country
5.1.1 North America Imatinib Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Imatinib Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Imatinib Drug Sales and Growth Rate (2015-2020)
5.3 Canada Imatinib Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Imatinib Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Imatinib Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Imatinib Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Imatinib Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Imatinib Drug Sales and Growth Rate (2015-2020)
6.3 UK Imatinib Drug Sales and Growth Rate (2015-2020)
6.4 France Imatinib Drug Sales and Growth Rate (2015-2020)
6.5 Russia Imatinib Drug Sales and Growth Rate (2015-2020)
6.6 Italy Imatinib Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Imatinib Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Imatinib Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Imatinib Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Imatinib Drug Sales and Growth Rate (2015-2020)
7.3 Japan Imatinib Drug Sales and Growth Rate (2015-2020)
7.4 Korea Imatinib Drug Sales and Growth Rate (2015-2020)
7.5 India Imatinib Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Imatinib Drug Sales and Growth Rate (2015-2020)
7.7 Australia Imatinib Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Imatinib Drug Sales, Revenue and Market Share by Country
8.1.1 South America Imatinib Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Imatinib Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Imatinib Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Imatinib Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Imatinib Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Imatinib Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Imatinib Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Imatinib Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Imatinib Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Imatinib Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Imatinib Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Imatinib Drug Sales and Market Share by Type (2015-2020)
10.2 Global Imatinib Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Imatinib Drug Price by Type (2015-2020)
11 Global Imatinib Drug Market Segment by Application
11.1 Global Imatinib Drug Sales Market Share by Application (2015-2020)
11.2 Global Imatinib Drug Revenue Market Share by Application (2015-2020)
11.3 Global Imatinib Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Imatinib Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Imatinib Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Imatinib Drug Market Forecast (2021-2025)
12.2.2 Europe Imatinib Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Imatinib Drug Market Forecast (2021-2025)
12.2.4 South America Imatinib Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Imatinib Drug Market Forecast (2021-2025)
12.3 Imatinib Drug Market Forecast by Type (2021-2025)
12.3.1 Global Imatinib Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Imatinib Drug Market Share Forecast by Type (2021-2025)
12.4 Imatinib Drug Market Forecast by Application (2021-2025)
12.4.1 Global Imatinib Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Imatinib Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Imatinib Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Imatinib Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Imatinib Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Imatinib Drug Major Business
Table 9. Novartis Imatinib Drug Total Revenue (USD Million) (2017-2018)
Table 10. Novartis SWOT Analysis
Table 11. Novartis Imatinib Drug Product and Services
Table 12. Novartis Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Cipla Inc. Basic Information, Manufacturing Base and Competitors
Table 14. Cipla Inc. Imatinib Drug Major Business
Table 15. Cipla Inc. Imatinib Drug Total Revenue (USD Million) (2017-2018)
Table 16. Cipla Inc. SWOT Analysis
Table 17. Cipla Inc. Imatinib Drug Product and Services
Table 18. Cipla Inc. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Actavis Generics Basic Information, Manufacturing Base and Competitors
Table 20. Actavis Generics Imatinib Drug Major Business
Table 21. Actavis Generics Imatinib Drug Total Revenue (USD Million) (2017-2018)
Table 22. Actavis Generics SWOT Analysis
Table 23. Actavis Generics Imatinib Drug Product and Services
Table 24. Actavis Generics Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Glenmark Pharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors
Table 26. Glenmark Pharmaceuticals Ltd. Imatinib Drug Major Business
Table 27. Glenmark Pharmaceuticals Ltd. Imatinib Drug Total Revenue (USD Million) (2017-2018)
Table 28. Glenmark Pharmaceuticals Ltd. SWOT Analysis
Table 29. Glenmark Pharmaceuticals Ltd. Imatinib Drug Product and Services
Table 30. Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table 32. Sanofi S.A. Imatinib Drug Major Business
Table 33. Sanofi S.A. Imatinib Drug Total Revenue (USD Million) (2017-2018)
Table 34. Sanofi S.A. SWOT Analysis
Table 35. Sanofi S.A. Imatinib Drug Product and Services
Table 36. Sanofi S.A. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Sun Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 38. Sun Pharmaceuticals Imatinib Drug Major Business
Table 39. Sun Pharmaceuticals Imatinib Drug Total Revenue (USD Million) (2017-2018)
Table 40. Sun Pharmaceuticals SWOT Analysis
Table 41. Sun Pharmaceuticals Imatinib Drug Product and Services
Table 42. Sun Pharmaceuticals Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Mylan Pharms Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Mylan Pharms Inc. Imatinib Drug Major Business
Table 45. Mylan Pharms Inc. Imatinib Drug Total Revenue (USD Million) (2017-2018)
Table 46. Mylan Pharms Inc. SWOT Analysis
Table 47. Mylan Pharms Inc. Imatinib Drug Product and Services
Table 48. Mylan Pharms Inc. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 50. Teva Pharmaceutical Industries Ltd. Imatinib Drug Major Business
Table 51. Teva Pharmaceutical Industries Ltd. Imatinib Drug Total Revenue (USD Million) (2017-2018)
Table 52. Teva Pharmaceutical Industries Ltd. SWOT Analysis
Table 53. Teva Pharmaceutical Industries Ltd. Imatinib Drug Product and Services
Table 54. Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 56. Dr. Reddy's Laboratories Imatinib Drug Major Business
Table 57. Dr. Reddy's Laboratories Imatinib Drug Total Revenue (USD Million) (2017-2018)
Table 58. Dr. Reddy's Laboratories SWOT Analysis
Table 59. Dr. Reddy's Laboratories Imatinib Drug Product and Services
Table 60. Dr. Reddy's Laboratories Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Apotex Inc. Basic Information, Manufacturing Base and Competitors
Table 62. Apotex Inc. Imatinib Drug Major Business
Table 63. Apotex Inc. Imatinib Drug Total Revenue (USD Million) (2017-2018)
Table 64. Apotex Inc. SWOT Analysis
Table 65. Apotex Inc. Imatinib Drug Product and Services
Table 66. Apotex Inc. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Imatinib Drug Sales by Manufacturer (2018-2019) (K Units)
Table 68. Global Imatinib Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Imatinib Drug Sales by Regions (2015-2020) (K Units)
Table 70. Global Imatinib Drug Sales Market Share by Regions (2015-2020)
Table 71. Global Imatinib Drug Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Imatinib Drug Sales by Countries (2015-2020) (K Units)
Table 73. North America Imatinib Drug Sales Market Share by Countries (2015-2020)
Table 74. North America Imatinib Drug Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Imatinib Drug Revenue Market Share by Countries (2015-2020)
Table 76. Europe Imatinib Drug Sales by Countries (2015-2020) (K Units)
Table 77. Europe Imatinib Drug Sales Market Share by Countries (2015-2020)
Table 78. Europe Imatinib Drug Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Imatinib Drug Sales by Regions (2015-2020) (K Units)
Table 80. Asia-Pacific Imatinib Drug Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Imatinib Drug Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Imatinib Drug Sales by Countries (2015-2020) (K Units)
Table 83. South America Imatinib Drug Sales Market Share by Countries (2015-2020)
Table 84. South America Imatinib Drug Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Imatinib Drug Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Imatinib Drug Sales by Countries (2015-2020) (K Units)
Table 87. Middle East & Africa Imatinib Drug Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Imatinib Drug Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Imatinib Drug Revenue Market Share by Countries (2015-2020)
Table 90. Global Imatinib Drug Sales by Type (2015-2020) (K Units)
Table 91. Global Imatinib Drug Sales Share by Type (2015-2020)
Table 92. Global Imatinib Drug Revenue by Type (2015-2020) (USD Million)
Table 93. Global Imatinib Drug Revenue Share by Type (2015-2020)
Table 94. Global Imatinib Drug Sales by Application (2015-2020) (K Units)
Table 95. Global Imatinib Drug Sales Share by Application (2015-2020)
Table 96. Global Imatinib Drug Sales Forecast by Regions (2021-2025) (K Units)
Table 97. Global Imatinib Drug Market Share Forecast by Regions (2021-2025)
Table 98. Global Imatinib Drug Sales Forecast by Type (2021-2025) (K Units)
Table 99. Global Imatinib Drug Market Share Forecast by Type (2021-2025)
Table 100. Global Imatinib Drug Sales Forecast by Application (2021-2025)
Table 101. Global Imatinib Drug Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Imatinib Drug Picture
Figure 2. Global Sales Market Share of Imatinib Drug by Type in 2019
Figure 3. Tablets Picture
Figure 4. Capsules Picture
Figure 5. Imatinib Drug Sales Market Share by Application in 2018
Figure 6. Chronic myelogenous leukemia Picture
Figure 7. Gastrointestinal stromal tumors Picture
Figure 8. Others Picture
Figure 9. Global Imatinib Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Imatinib Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Imatinib Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Imatinib Drug Sales Market Share by Manufacturer in 2019
Figure 30. Global Imatinib Drug Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Imatinib Drug Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Imatinib Drug Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Imatinib Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Imatinib Drug Revenue Market Share by Regions (2015-2020)
Figure 37. Global Imatinib Drug Revenue Market Share by Regions in 2018
Figure 38. North America Imatinib Drug Sales and Growth Rate (2015-2020)
Figure 39. Europe Imatinib Drug Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Imatinib Drug Sales and Growth Rate (2015-2020)
Figure 41. South America Imatinib Drug Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Imatinib Drug Sales and Growth Rate (2015-2020)
Figure 43. North America Imatinib Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Imatinib Drug Sales Market Share by Countries (2015-2020)
Figure 45. North America Imatinib Drug Sales Market Share by Countries in 2018
Figure 46. North America Imatinib Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Imatinib Drug Revenue Market Share by Countries in 2018
Figure 48. United States Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Imatinib Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Imatinib Drug Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Imatinib Drug Revenue Market Share by Countries in 2019
Figure 54. Germany Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Imatinib Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Imatinib Drug Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Imatinib Drug Revenue Market Share by Regions 2019
Figure 62. China Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Imatinib Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Imatinib Drug Sales Market Share by Countries in 2019
Figure 69. South America Imatinib Drug Revenue Market Share by Countries in 2019
Figure 70. Brazil Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Imatinib Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Imatinib Drug Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Imatinib Drug Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Imatinib Drug Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Imatinib Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Imatinib Drug Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Imatinib Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Imatinib Drug Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Imatinib Drug Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Imatinib Drug Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Imatinib Drug Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Imatinib Drug Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
イマチニブメシル酸塩の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Imatinib Mesylate market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Imatinib Mesylate market re…- 植物薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Botanical Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Botanical Drug market report p…
- 薬物乱用検査サービスの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Drug of Abuse Testing Services market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.7% in the forecast period of 2020 to 2025 and will expected to reach USD 4790.3 million by 2025, from USD 4313 million in 2019. The Drug of…
- アレルギー鼻炎薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Allergy Rhinitis Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Allergy Rhinitis Drug m…
- ドラッグデリバリーにおけるナノテクノロジーの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Nanotechnology in Drug Delivery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.8% in the forecast period of 2020 to 2025 and will expected to reach USD 8000.6 million by 2025, from USD 6153.4 million in 2019. The Nano…